Nomi Health Expands Community Testing to Include All-in-One Test for Influenza, COVID
Nomi Health is expanding its testing offerings to include influenzas A and B at its Utah COVID-19 testing sites.
Nomi Health is expanding its testing offerings to include influenzas A and B at its Utah COVID-19 testing sites.
Researchers have discovered a high prevalence of COVID co-infections in central Missouri during the 2021-2022 flu season.
Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings.
The cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Read MoreGT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2) as well as testing and PCR kits for the detection of Influenza A and B.
Read MoreResearchers showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness and the test provided results in under an hour.
Read MoreTesting integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of covid-19 and its viral mutations, as well as Influenza A, B, and more.
Read MoreThis winter has been an extraordinarily quiet flu season. Scientists aren’t sure the silence will last, according to a report in The Atlantic.
Read MoreQuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MoreNew research has shown that implementing point-of-care testing in hospitals to diagnose influenza can lead to better treatment and faster recovery for patients.
Read MoreThe new EuroRealTime test allows fast detection and differentiation of genetic material from SARS-CoV-2, influenza virus type A, and influenza virus type B using throat swab samples of patients with acute symptoms.
Read MoreThe PKamp Respiratory SARS-CoV-2 RT-PCR Panel enables differential diagnosis between covid-19, flu, and RSV infections.
Read MoreThe FDA has issued and immediately implemented a new guidance: Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.
Read MoreThe Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
Read MoreThe Simplexa Flu A/B & RSV Direct Gen II assay can be run alone or alongside the Simplexa Covid-19 Direct kit.
Read MoreRoutine use of the positive run control enables laboratories to meet their individualized quality control goals, including evaluation of reagent lot changes and new shipments.
Read MoreThe panel tests nasopharyngeal swabs for the most common respiratory viruses and bacteria.
Read MoreThe panel test detects Pneumocystis jirovecii in addition to a broad spectrum of clinically relevant bacterial pathogens and antibiotic-resistance markers associated with pneumonia.
Read More